Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Alzheimer's Disease
Recent news which mentions Alzheimer's Disease
< Previous
1
2
3
4
Next >
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
March 22, 2022
Tickers
BIIB
ESALF
ESALY
Tags
ESALF
News
Health Care
From
Benzinga
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
March 16, 2022
Tickers
BIIB
Tags
Benzinga
Alzheimer's disease
News
From
Benzinga
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
March 16, 2022
Tickers
PRTA
Tags
PRTA
News
Health Care
From
Benzinga
Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs
March 15, 2022
Tickers
GANX
Tags
Movers
Trading Ideas
Benzinga
From
Benzinga
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
March 15, 2022
Tickers
BIIB
ESALF
ESALY
Tags
Benzinga
Alzheimer's disease
ESALY
From
Benzinga
AC Immune-Janssen Partnered Alzheimer's Vaccine Shows Tau-Specific Antibodies In Early-Stage Trial
February 15, 2022
Tickers
ACIU
JNJ
Tags
Movers
Trading Ideas
Benzinga
From
Benzinga
Eli Lilly Plans To Invest €400M In Manufacturing Facility In Ireland: Report
January 28, 2022
Tickers
LLY
Tags
Briefs
Market News
LLY
From
Benzinga
Cortexyme Stock Plunges On FDA Hold On Atuzaginstat's IND
January 26, 2022
Tickers
CRTX
Tags
FDA
Health Care
News
From
Benzinga
FDA Places Clinical Hold On Denali's Alzheimer's Potential Program
January 13, 2022
Tickers
DNLI
Tags
Alzheimer's Drugs
News
Health Care
From
Benzinga
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
January 12, 2022
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Biotech
General
RHHVF
From
Benzinga
Exclusive: Longeveron Kickstarts Its Mid-Stage Alzheimer's Disease Trial
January 05, 2022
Tickers
LGVN
Tags
Market News
Exclusives
LGVN
From
Benzinga
Why Hoth Therapeutics Stock Is Soaring Today?
January 04, 2022
Tickers
HOTH
Tags
Long Ideas
Market News
HOTH
From
Benzinga
Why Biogen's Alzheimer's drug Aduhelm is so controversial
January 04, 2022
Tags
Business
Health Insurance
Baby Boomers
From
CNBC.com News
Medicare Trying To Determine Coverage Of Biogen's Expensive Alzheimer's Drug: NYT
January 03, 2022
Tickers
BIIB
Tags
BIIB
Market News
Briefs
From
Benzinga
Acadia Slims Nuplazid Label Expansion Application For Alzheimer's Disease Psychosis
December 21, 2021
Tickers
ACAD
Tags
Market News
Briefs
FDA
From
Benzinga
After Much Criticism, Biogen Slashes Aduhelm Price In Half
December 20, 2021
Tickers
BIIB
Tags
Briefs
Market News
News
From
Benzinga
Alzamend Neuro Shares Are Trading Higher After Encourage Early-Stage Data From Alzheimer's Candidate
December 17, 2021
Tickers
ALZN
Tags
Biotech
General
Benzinga
From
Benzinga
EMA's Committee Gives Thumbs Down To Biogen's Controversial Alzheimer's Drug, As Expected
December 17, 2021
Tickers
BIIB
Tags
Alzheimer's disease
Benzinga
Movers
From
Benzinga
Biogen Outlines Aduhelm's Confirmatory Trial Plans, Data Expected In 2026
December 16, 2021
Tickers
BIIB
ESALF
ESALY
Tags
FDA
ESALF
News
From
Benzinga
Amid Shaky Launch Of Aduhelm, Biogen Mulls Substantial Layoffs: STAT News Report
December 10, 2021
Tickers
BIIB
Tags
Biotech
General
BIIB
From
Benzinga
Can Pfizer's Viagra Help In Alzheimer's? Cleveland Clinic Study Shows Potential
December 06, 2021
Tickers
PFE
Tags
General
Biotech
Market News
From
Benzinga
Thanksgiving Left-Overs 2021
November 30, 2021
Tags
Alzheimer's Disease
potassium
sodium
From
Stock Gumshoe
Waiting to talk finance with an aging parent in cognitive decline is a mistake, experts say
November 30, 2021
Tags
Legal services
Advisor Insight
Baby Boomers
From
CNBC.com News
Cassava Sciences Kickstarts Second Late-Stage Alzheimer's Trial With Simufilam
November 18, 2021
Tickers
SAVA
Tags
Biotech
Phase 3 Trial
General
From
Benzinga
European Regulator Votes Down Biogen's Alzheimer's Drug
November 17, 2021
Tickers
BIIB
Tags
News
Health Care
European Medicines Agency
From
Benzinga
Why Are Biogen Shares Gaining Today?
November 12, 2021
Tickers
BIIB
ESALF
ESALY
Tags
Briefs
Market News
why it's moving
From
Benzinga
Eisai Posts New Lecanemab Data From Mid-Stage Alzheimer's Trial
November 11, 2021
Tickers
BIIB
ESALF
ESALY
Tags
BIIB
Biotech
General
From
Benzinga
Why Are Cortexyme Shares Falling Today?
November 11, 2021
Tickers
CRTX
Tags
News
Health Care
Market News
From
Benzinga
Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters
November 10, 2021
Tickers
BIIB
LLY
RHHBF
RHHBY
Tags
RHHVF
General
Biotech
From
Benzinga
Why Did Cassava Sciences Stock Jump 49% Today?
November 04, 2021
Tickers
SAVA
Tags
Biotech
General
Alzheimer's disease
From
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today